Bloodworks
FDA inspection history in Seattle, Washington, 2024
- 1
- Form 483
Every document, by year
- Form 483
2024: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2024One Form 483, at Seattle, Washington.
Cited most
Across all Bloodworks observations on file
- 21 CFR 211.84(d)(1)Testing and approval or rejection of components, drug product containers, and closures1
The complete Bloodworks file.
All 1 documents as original PDFs. For supplier audits, diligence and inspection prep.
Sites
Seattle, Washington
One Form 483 · 2024 · 1 observation
Latest: Form 483, May 3, 2024 →
Documents
1 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2024-05-03 | 483 Form 483 | Seattle, Washington | 1 | $99 |
Investigators on these documents
FEI number 3071347 · most recent document May 3, 2024
About Bloodworks
How many FDA Form 483s has Bloodworks received?
FDA Intel has 1 Form 483 on file for Bloodworks; the most recent is dated May 3, 2024.
When was Bloodworks last inspected by FDA?
The most recent FDA inspection document on file for Bloodworks is a Form 483 dated May 3, 2024, for the site in Seattle, Washington.
What did FDA cite at Bloodworks?
The regulations cited most in the observations on file for Bloodworks are 21 CFR 211.84(d)(1) (Testing and approval or rejection of components, drug product containers, and closures), 1 time.